Science 37 Holdings Stock Net Asset
| SNCEDelisted Stock | USD 0.28 0.02 7.69% |
Science 37 Holdings fundamentals help investors to digest information that contributes to Science 37's financial success or failures. It also enables traders to predict the movement of Science Stock. The fundamental analysis module provides a way to measure Science 37's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Science 37 stock.
Science |
Science 37 Holdings Company Net Asset Analysis
Science 37's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Science 37 Net Asset | 126.45 M |
Most of Science 37's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Science 37 Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
CompetitionBased on the recorded statements, Science 37 Holdings has a Net Asset of 126.45 M. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
Science Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Science 37's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Science 37 could also be used in its relative valuation, which is a method of valuing Science 37 by comparing valuation metrics of similar companies.Science 37 is currently under evaluation in net asset category among its peers.
Science Fundamentals
| Return On Equity | -1.19 | |||
| Return On Asset | -0.28 | |||
| Profit Margin | (2.07) % | |||
| Operating Margin | (0.60) % | |||
| Current Valuation | (21.22 M) | |||
| Shares Outstanding | 6.03 M | |||
| Shares Owned By Insiders | 16.89 % | |||
| Shares Owned By Institutions | 52.18 % | |||
| Number Of Shares Shorted | 13.83 K | |||
| Price To Book | 0.67 X | |||
| Price To Sales | 0.58 X | |||
| Revenue | 60.26 M | |||
| Gross Profit | 20.07 M | |||
| EBITDA | (59.86 M) | |||
| Net Income | (124.65 M) | |||
| Cash And Equivalents | 130.24 M | |||
| Cash Per Share | 1.12 X | |||
| Total Debt | 1.32 M | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 6.32 X | |||
| Book Value Per Share | 8.69 X | |||
| Cash Flow From Operations | (48.19 M) | |||
| Short Ratio | 0.22 X | |||
| Earnings Per Share | (21.40) X | |||
| Target Price | 13.83 | |||
| Number Of Employees | 460 | |||
| Beta | 0.56 | |||
| Market Capitalization | 34.66 M | |||
| Total Asset | 126.45 M | |||
| Retained Earnings | (253.07 M) | |||
| Working Capital | 103.03 M | |||
| Z Score | 12.82 | |||
| Net Asset | 126.45 M |
About Science 37 Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Science 37 Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Science 37 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Science 37 Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Science Stock
If you are still planning to invest in Science 37 Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Science 37's history and understand the potential risks before investing.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |